BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27101150)

  • 1. RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1.
    Weng XQ; Sheng Y; Ge DZ; Wu J; Shi L; Cai X
    Leuk Res; 2016 Jun; 45():68-74. PubMed ID: 27101150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK.
    Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X
    Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK.
    Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Cai X
    Food Chem Toxicol; 2019 Apr; 126():303-312. PubMed ID: 30840849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of
    Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
    J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines.
    Ge DZ; Sheng Y; Cai X
    Sci Rep; 2014 Apr; 4():4821. PubMed ID: 24769642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staurosporine enhances ATRA-induced granulocytic differentiation in human leukemia U937 cells via the MEK/ERK signaling pathway.
    Shi L; Weng XQ; Sheng Y; Wu J; Ding M; Cai X
    Oncol Rep; 2016 Nov; 36(5):3072-3080. PubMed ID: 27665842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid.
    Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takei M; Takeuchi J; Takagi N; Toyoda H
    Int J Oncol; 2014 Mar; 44(3):865-73. PubMed ID: 24379003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
    Duprez E; Wagner K; Koch H; Tenen DG
    EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
    Song G; Shi L; Guo Y; Yu L; Wang L; Zhang X; Li L; Han Y; Ren X; Guo Q; Bi K; Jiang G
    Oncotarget; 2016 Jan; 7(3):3144-57. PubMed ID: 26673819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
    Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
    Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway.
    Huai L; Wang C; Zhang C; Li Q; Chen Y; Jia Y; Li Y; Xing H; Tian Z; Rao Q; Wang M; Wang J
    Biochem Biophys Res Commun; 2012 Jun; 422(3):398-404. PubMed ID: 22575507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
    Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
    J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
    Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A
    Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
    Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
    Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
    Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
    BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
    Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
    Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.
    Li ZY; Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Lu H; Cai X
    Am J Transl Res; 2020; 12(12):7836-7854. PubMed ID: 33437364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Ethacrynic Acid and ATRA Triggers Differentiation and/or Apoptosis of Acute Myeloid Leukemia Cells through ROS.
    Li L; Xi HM; Lu H; Cai X
    Anticancer Agents Med Chem; 2024; 24(6):412-422. PubMed ID: 38204257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.